Temozolomide (TMZ) and radiation therapy (RT) combination in elderly patients with glioblastoma: A multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).

被引：0
|
作者：
Lombardi, Giuseppe
Pace, Andrea
Pasqualetti, Francesco
Rizzato, Simona
Faedi, Marina
Anghileri, Elena
Nicolotto, Elisa
Bazzoli, Elena
Bellu, Luisa
Villani, Veronica
Fabi, Alessandra
Ferrazza, Patrizia
Gurrieri, Lorena
Dall'Agata, Monia
Eoli, Marica
Della Puppa, Alessandro
Pambuku, Ardi
D'Avella, Domenico
Ruda, Roberta
Zagonel, Vittorina
机构：
[1] Veneto Inst Oncol IRCCS, Med Oncol 1, Dept Clin & Expt Oncol, Padua, Italy
[2] Regina Elena Inst Canc Res, Neurooncol Unit, Rome, Italy
[3] Azienda Osped Univ Pisana, Dept Radiotherapy, Pisa, Italy
[4] Azienda Osped Univ Udine, Dept Oncol, Udine, Italy
[5] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Dept Med Oncol, Meldola, Italy
[6] Fdn IRCCS Ist Neurol C Besta, Unit Mol Neurooncol, Milan, Italy
[7] Univ Turin, Dept Neurooncol, Turin, Italy
[8] City Hlth & Sci, Turin, Italy
[9] Univ Verona, Dept Neurol & Movement Sci, I-37100 Verona, Italy
[10] Ctr S Giovanni di Dio Fatebenefratelli, IRCCS, Brescia, Italy
[11] Regina Elena Inst Canc Res, Div Med Oncol, Rome, Italy
[12] Ist Sci Romagnolo Studio & Cura Tumori IRST IRCCS, Biostat & Clin Trials Unit, Meldola, Italy
[13] Fdn IRCCS Ist Neurol Carlo Besta, Milan, Italy
[14] Azienda Osped Padova, Dept Neurosurg, Padua, Italy
[15] Univ Padua, Dept Neurosurg, Padua, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e13003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13003
引用
收藏
页数：1
相关论文
共 50 条
  • [41] PAMIPARIB IN COMBINATION WITH RADIATION THERAPY (RT) AND/OR TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED OR RECURRENT/REFRACTORY (R/R) GLIOBLASTOMA (GBM); PHASE 1B/2 STUDY UPDATE
    Piotrowski, Anna
    Puduvalli, Vinay
    Wen, Patrick
    Campian, Jian
    Colman, Howard
    Pearlman, Michael
    Butowski, Nicholas
    Battiste, James
    Glass, Jon
    Cloughesy, Timothy
    Schiff, David
    van den Bent, Martin
    Walbert, Tobias
    Ahluwalia, Manmeet
    Badruddoja, Michael
    Kalra, Amandeep
    Aregawi, Dawit
    Weller, Michael
    Ramakrishnan, Vanitha
    Zhang, Kathy
    Wood, Katie
    Mellinghoff, Ingo
    Shih, Kent
    NEURO-ONCOLOGY, 2019, 21 : 21 - 22
  • [42] BEVACIZUMAB (BV) IN COMBINATION TO TEMOZOLOMIDE (TMZ) AND RADIATION THERAPY (RT) FOLLOWED BY BV, TMZ, AND IRINOTECAN (CPT-11) FOR NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM): A PHASE 2 TRIAL
    Desjardins, Annick
    Reardon, David A.
    Peters, Katherine B.
    Herndon, James
    Kirkpatrick, John
    Gururangan, Sridharan
    Sampson, John H.
    Friedman, Allan H.
    Friedman, Henry
    Vredenburgh, James J.
    NEURO-ONCOLOGY, 2009, 11 (05) : 634 - 634
  • [43] PAMIPARIB IN COMBINATION WITH RADIATION THERAPY (RT) AND/OR TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED (ND) OR RECURRENT/REFRACTORY (R/R) GLIOBLASTOMA (GBM); PHASE 1B/2 STUDY UPDATE
    Piotrowski, Anna
    Puduvalli, Vinay
    Wen, Patrick
    Colman, Howard
    Campian, Jian
    Pearlman, Michael
    Butowski, Nicholas
    Cloughesy, Timothy
    Battiste, James
    Glass, Jon
    Schiff, David
    van den Bent, Martin
    Walbert, Tobias
    Ahluwalia, Manmeet
    Badruddoja, Michael
    Kalra, Amandeep
    Pelham, Robert
    Zhang, Kathy
    Wood, Katie
    Weller, Michael
    Shih, Kent
    NEURO-ONCOLOGY, 2020, 22 : 51 - 51
  • [44] Deep neural networks for neuro-oncology: Towards patient individualized design of chemo-radiation therapy for Glioblastoma patients
    Zade, Amir Ebrahimi
    Haghighi, Seyedhamidreza Shahabi
    Soltani, M.
    JOURNAL OF BIOMEDICAL INFORMATICS, 2022, 127
  • [45] Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016
    Ruda, Roberta
    Pellerino, Alessia
    Pace, Andrea
    Carapella, Carmine Maria
    Dealis, Cristina
    Caroli, Manuela
    Faedi, Marina
    Bello, Lorenzo
    Migliore, Enrica
    Marchese, Giulia
    Bertero, Luca
    Cassoni, Paola
    Soffietti, Riccardo
    JOURNAL OF NEURO-ONCOLOGY, 2019, 145 (01) : 115 - 123
  • [46] Results of NRG oncology/RTOG 9813: A phase III randomized study of radiation therapy (RT) and temozolomide (TMZ) versus RT and nitrosourea (NU) therapy for anaplastic astrocytoma (AA)
    Chang, Susan Marina
    Zhang, Peixin
    Cairncross, J. Gregory
    Gilbert, Mark R.
    Bahary, Jean-Paul
    Dolinskas, Carol
    Aldape, Kenneth D.
    Chakravarti, Arnab
    Schiff, David
    Jaeckle, Kurt A.
    Brown, Paul D.
    Barger, Geoffrey
    Werner-Wasik, Maria
    Shih, Helen Alice
    Brachman, David
    Penas-Prado, Marta
    Robins, H. Ian
    Belanger, Karl
    Schultz, Christopher J.
    Mehta, Minesh P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [47] Adjuvant chemotherapy after severe myelotoxicity during chemoradiation phase in malignant gliomas. Is it feasibile? Results from AINO study (Italian Association for Neuro-Oncology)
    Veronica Villani
    Elena Anghileri
    Luca Prosperini
    Giuseppe Lombardi
    Roberta Rudà
    Paola Gaviani
    Simona Rizzato
    Gaetano Lanzetta
    Alessandra Fabi
    Claudia Scaringi
    Edoardo Pronello
    Giorgia Simonetti
    Giada Targato
    Andrea Pace
    Journal of Neurology, 2021, 268 : 2866 - 2875
  • [48] Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016
    Roberta Rudà
    Alessia Pellerino
    Andrea Pace
    Carmine Maria Carapella
    Cristina Dealis
    Manuela Caroli
    Marina Faedi
    Lorenzo Bello
    Enrica Migliore
    Giulia Marchese
    Luca Bertero
    Paola Cassoni
    Riccardo Soffietti
    Journal of Neuro-Oncology, 2019, 145 : 115 - 123
  • [49] EFFICACY OF INITIAL TEMOZOLOMIDE FOR HIGH-RISK LOW GRADE GLIOMAS IN A PHASE II AINO (ITALIAN ASSOCIATION FOR NEURO-ONCOLOGY) STUDY: A POST-HOC ANALYSIS WITHIN MOLECULAR SUBGROUPS OF WHO 2016
    Ruda, Roberta
    Pellerino, Alessia
    Pace, Andrea
    Carapella, Carmine Maria
    Dealis, Cristina
    Caroli, Manuela
    Faedi, Marina
    Bello, Lorenzo
    Migliore, Enrica
    Marchese, Giulia
    Bertero, Luca
    Cassoni, Paola
    Soffietti, Riccardo
    NEURO-ONCOLOGY, 2019, 21 : 16 - 17
  • [50] Phase 1b/2 study to assess the clinical effects of BGB-290 in combination with radiation therapy (RT) and/or temozolomide (TMZ) in patients with first-line or recurrent/refractory glioblastoma
    Wen, P. Y.
    Shih, K.
    Schiff, D.
    Brachmann, R.
    Weitzman, R.
    Cloughesy, T.
    ANNALS OF ONCOLOGY, 2017, 28
12345